Abstract Details

Title Genetically Engineering Neural Cell Lines with Multiple Levels of DOPA Regulation for Transplantation in Animal Models of Parkinson's Disease

Topic Movement Disorders

Presentation(s) (-)

Poster/Presentation
Number 151

Objective

Background

Design/Methods

Results

Conclusions

Authors/Disclosures
Trishna Kantamneni, MBBS (UC Davis Medical Center)	Dr. Kantamneni has nothing to disclose.
Matthew Swan, MD, FAAN	The institution of Dr. Swan has received research support from Biogen. The institution of Dr. Swan has received research support from Sage Therapeutics. The institution of Dr. Swan has received research support from Parkinson's Foundation. The institution of Dr. Swan has received research support from Photopharmics. The institution of Dr. Swan has received research support from Denali Therapeutics. The institution of Dr. Swan has received research support from NOEMA Pharma.
Lileth Joy H. Mondok, MD (MCW - Children'S Hospital of Wisconsin)	No disclosure on file
Neil R. Friedman, MD, MBChB (Phoenix Children's Hospital)	No disclosure on file
	No disclosure on file

��ɫ��